- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis in America Medical Cannabis Access for Pain Treatment
- Join Join
Louisiana Medical Marijuana Laws and Regulations
In 2015, Louisiana attempted to update it dormant medical cannabis law with the passage of SB 143, the Alison Neustrom Act. While a good symbolic step for the state to take, it did not do anything to help the patients of the state have safe and legal access to medical cannabis therapy. The state regrettably used the term “prescribe” rather than “recommend” in its physician authorizing language, but due to the federal Schedule I status of cannabis, no physician will be able to write prescriptions unless there is a major change at the federal level.
However, in 2016, the state passed and signed a pair of bills - SB 271 and SB 180. The pair of bills fixes the “prescription” language issue, establishes legal protection for patients, and expands the qualifying conditions. Legal protections for producers and dispensers is left unaddressed, which could prevent the program from functioning.
SB 271 (2016) - "prescription language fix"
SB 180 (2016) - establishing prosecution protection for patients